Suckling rat brain regional distribution of Na+,K +-ATPase activity in the in vitro galactosaemia: The effect of L-cysteine and glutathione

Metabolic Brain Disease

Volumn 20, Issue 1, 2005, Pages 45-54

  Marinou, Kyriakoula ^a   Tsakiris, Stylianos ^a   Tsopanakis, Christi ^a   Schulpis, Kleopatra H ^b   Behrakis, Panagiotis ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

(Na +,K+) ATPase; Cysteine; Galactitol; Galactosaemia; Galactose 1 phosphate; GSH

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYSTEINE; GALACTITOL; GALACTOKINASE; GALACTOSE; GALACTOSE PHOSPHATE; GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FRONTAL CORTEX; GALACTOSEMIA; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; OXIDATION; RAT; SUPPLEMENTATION;

ANIMALS; ANIMALS, SUCKLING; ANTIOXIDANTS; BRAIN; BRAIN CHEMISTRY; CYSTEINE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; FREE RADICALS; GALACTITOL; GALACTOSE; GALACTOSEMIAS; GALACTOSEPHOSPHATES; GLUTATHIONE; MALE; NA(+)-K(+)-EXCHANGING ATPASE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUBCELLULAR FRACTIONS;

EID: 18844461197     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-005-2475-0     Document Type: Article

References (30)

1. Berry, G.T., and Segal, S. (2000), Disorders of galactose metabolism. In (C.R. Scriver, A.L. Beadet, W.S. Sly, and D. Valle, eds.), The Metabolic and Molecular Basis of Inherited Disorders, McGraw Hill, New York, pp. 1553-1589.
2. Berry, G.T., Leslie, N., Reynolds, R., Yaken, C., and Segal, S. (2001). Evidence for alternative galactose oxidation in a patient with detection of the galactose-1-phosphate uridyltransferase gene. Mol. Gen. Metab. 72:316-321.
3. Berry, G.T., Nissim, I., Lin, Z., Mazur, A.T., Gibson, J.B., and Segal, S. (1995). Evidence for endogenous synthesis of galactose in normal man and patients with galactosaemia. Lancet 346:1073-1074.
4. Bogdanski, D.E., Tissuri, A., and Brodie, B.B. (1968), Role of sodium, potassium, ouebain and reserpine in uptake, storage and metabolism of biogenic amines in synaptosomes. Life Sci. 7:419-428.
5. Bosch, A.M., Bakker, A.M., Van Genni, P., Vankempen, J.V., Wanders, R.J.A., and Wuburg, A. (2003). Clinical features of galactokinase deficiency. A review of the literature. J. Inherit. Metab. 25:629-634.
6. Bowler, K., and Tirri, R. (1974). The temperature characteristics of synaptic membrane ATPases from immature and adult rat brain. J. Neurochem. 23:611-613.
7. Committee on Care and Use of Laboratory Animals. (1985). Guide for The Care and Use of Laboratory Animals. Institute of Laboratory Animals Resources, National Research Council, Washington, DC, p. 83.
8. Ericinska, M., and Silver, J.A. (1994). Silver, ions and energy in mammalian brain. Prog. Neurobiol. 16:37-41.
9. Guyton, A.C. (2000). Textbook of medical physiology. W.B. Saunders, Philadelphia, pp. 1553-1589.
10. Herrero, E., Aragon, M.C., Gimenez, C., and Valdivieso, F. (1983). Inhibition by L-phenylalanine of tryptophane transport by synaptosomal plasma membrane vesicles: Implications in the pathogenesis of phenylketonuria. J. Inher. Metab. Dis. 6:32-35.
11. Holton, J.B., (1996). Galactosaemia: Pathogenesis and treatment. J. Inher. Metab. Dis. 19:3-7.
12. Jakobs, C., Schweitzer, S., and Dorland, B. (1993). Galactitol in galactosemia. Eur. J. Paediatr. 154(S2):550-555.
13. +-ATPaSe: Functional Sites and their Interactions. Annu. Rev. Physiol. 65:817-849.
14. +-ATPase. Annu. Rev. Biochem. 71:511-535.
15. Lees, G.J. (1993) Contributory mechanism in the causation of neurodegenerative disorders. Neuroscience 54:287-322.
16. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, A.J., (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
17. Mefford, I.N. (1988). Epinephrine in mammalian brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 12:365-388.
18. Murakami, M., and Webb, M.A. (1981). A morphological and biochemical study of the effects of L-cysteine on the renal uptake and nephrotoxicity of cadmium. Br. J. Exp. Pathol. 62:115-130.
19. Palmieri, M., Mazur, A., and Berry, G.T. (1999). Urine and plasma galactitol in patients with galactose-1-phosphate uridyltranserase deficiency galactosaemia. Metabolism 48:1294-1302.
20. Sastry, B.S.R., and Phillis, J.W. (1977). Antagonism of biogenic amines induced depression of cerebral cortical neurons by Na,K ATPase inhibitors. Can. J. Physiol. Pharmacol. 55:170-180.
21. Schulpis, K.H., Papaconstantinou, E.D., Michelakakis, H., and Shin, Y. (1997). Screening for galactosaemia in Greece. Pediatr. Perinatal. Epidemiol. 11:436-440.
22. +-ATPaSe activity in the synaptic plasma membrane from the cerebral cortex of rats. Metab. Brain Dis. 15:105-114.
23. Sweadner, K.J., and Goldin, S.M. (1980). Active transport of sodium and potassium ions mechanism, function and regulation. N. Eng. J. Med. 302:777-783.
24. Townsend, D., Twe, K.D., and Tapiero, H. (2003). The importance of glutathione in human disease. Biomed. Pharmacother. 57:145-155.
25. +-ATPase inhibition induced by free radicals. Z. Naturforsch. 55c:271-277.
26. +-ATPase activity. Z. Naturforsch. 57c:939-943.
27. 2+-ATPaSe activities induced by the in vitro galactosaemia. Pharmacol. Res. 49:475-479.
28. Waggoner, D.D., Buist, N.M.R., and Donnell, G.N. (1990). Long- term prognosis in Galactosaemia: Results of a Survey of 350 Cases. J. Inher. Metab. Dis. 13:802-818.
29. +-ATPase activity in experimental phenylketonuria. Metab. Brain Dis. 14:95-101.
30. +-ATPase. Ann. N.Y. Acad. Sci. 834:680-683.